180 Life Sciences Corp. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity (Details) - Part-2

Stockholders' Equity (Details) - Part-2 - USD ($)									1 Months Ended		12 Months Ended
Stockholders' Equity (Details) - Part-2 - USD ($)	Nov. 28, 2023	Aug. 31, 2023	Apr. 30, 2023	Apr. 05, 2023	Jan. 05, 2023	Dec. 31, 2022	Jul. 31, 2022	Nov. 06, 2020	Dec. 20, 2022	Jul. 17, 2022	Dec. 31, 2023	Dec. 31, 2022
Stockholders' Equity [Line Items]
Preferred stock, shares authorized (in Shares)						5,000,000					5,000,000	5,000,000
Preferred stock, par value						$ 0.0001					$ 0.0001	$ 0.0001
Common stock, shares authorized (in Shares)						100,000,000					100,000,000	100,000,000
Common stock, par value						$ 0.0001					$ 0.0001	$ 0.0001
Aggregate shares (in Shares)				61,615						9,211
Exercise price per share		$ 3.23	$ 15.77			$ 15.77	$ 15.77
Exercise of warrants issued (in Shares)						197,209					534,719	197,209
Maximum [Member]
Stockholders' Equity [Line Items]
Exercise price per share											$ 402.8
Minimum [Member]
Stockholders' Equity [Line Items]
Exercise price per share											$ 33.82
Series A Preferred Stock [Member]
Stockholders' Equity [Line Items]
Preferred stock, shares authorized (in Shares)								5,000,000
Preferred stock, par value								$ 0.0001
Preferred shares issued (in Shares)								1,000,000
Preferred shares outstanding (in Shares)
Class K Preferred Stock [Member]
Stockholders' Equity [Line Items]
Preferred stock, shares authorized (in Shares)						1					1	1
Preferred shares issued (in Shares)						1					1	1
Special voting shares (in Shares)								1
Preferred shares outstanding (in Shares)						1					1	1
Class C Preferred Stock [Member]
Stockholders' Equity [Line Items]
Preferred stock, shares authorized (in Shares)						1					1	1
Preferred shares issued (in Shares)						1					1	1
Special voting shares (in Shares)								1
Preferred shares outstanding (in Shares)						1					1	1
Common Stock [Member]
Stockholders' Equity [Line Items]
Pre-funded warrants (in Shares)									11,316
July 2022 Pre-Funded Warrants [Member]
Stockholders' Equity [Line Items]
Aggregate shares (in Shares)										6,927
Common stock outstanding percent											9.99%
Pre-funded warrants (in Shares)											6,927
July 2022 Pre-Funded Warrants [Member] \| Pre-Funded Warrants (Member)
Stockholders' Equity [Line Items]
Pre-funded warrants (in Shares)											263
July 2022 Common Warrants [Member]
Stockholders' Equity [Line Items]
Aggregate shares (in Shares)										16,138
Common stock outstanding percent											4.99%	4.99%
Exercise price per share											$ 402.8
Warrants exercisable term											5 years
July 2022 Offering [Member]
Stockholders' Equity [Line Items]
Warrants exercise price										$ 402.8
Aggregate gross proceeds (in Dollars)										$ 6,499,737
Warrant Price [Member]
Stockholders' Equity [Line Items]
Warrants exercise price					$ 33.82
Pre funded warrants exercies price											$ 0.0019
Second Amendment to Common Warrant Agreements [Member]
Stockholders' Equity [Line Items]
Exercise price per share											15.77
Amendment to the August 2023 Offering [Member]
Stockholders' Equity [Line Items]
Warrants exercise price	$ 0.0019										3.23
Amendment to the August 2023 Offering [Member] \| July 2022 Offering [Member]
Stockholders' Equity [Line Items]
Exercise price per share											$ 3.23
Amendment to the August 2023 Offering [Member] \| Common Stock [Member]
Stockholders' Equity [Line Items]
Exercise of warrants issued (in Shares)											734,262